The 17th Annual HeLa Women's Health Conference will take place Friday, September 14, 2012 and is designed to heighten participants’ awareness of Stem Cell Development Continuum and the Bioethical considerations associated with use of embryonic stem cells.
Practicing Obstetricians and Gynecologists; students in training; perinatal healthcare delivery personnel; reproductive and environmental health specialists; social scientists; health policy officials; and community reproductive health activists.
At the conclusion of the conference, participants should be able to:
Define the arena of embryonic stem cells, distinguish point of origin from adult and embryonic sources.
Describe the capacity for umbilical cord blood cells to engraft and fully populate the depleted marrow.
Outline the ethical considerations of destruction of an embryo versus treatment of disease.
Describe umbilical cord blood collection and cryopreservation techniques.
Record the results of stem cell therapy in injury and diseases of the spinal cord.
Define some preliminary outcomes of regenerative medicine therapy.
Summarize umbilical cord blood translational cell therapy in cancer, metabolic diseases, cerebral palsy, congenital heart disease and in children with genetic or neurodegenerative disease.